In Vivo Adipogenesis in Rats Measured by Cell Kinetics in Adipocytes and Plastic-adherent Stroma-vascular Cells in Response to High-fat Diet and Thiazolidinedione
Overview
Authors
Affiliations
Impairment of adipogenesis contributes to the development of obesity-related insulin resistance. The current in vitro approaches for its assessment represent crude estimates of the adipogenic potential because of the disruption of the in vivo microenvironment. A novel assessment of in vivo adipogenesis using the incorporation of the stable isotope deuterium ((2)H) into the DNA of isolated adipocytes and stroma-vascular fraction from adipose tissue has been developed. In the current study, we have refined this technique by purifying the adipocytes via a negative immune selection and sorting the plastic adherent stroma-vascular (aSV) subfraction (using 3 h culture) that contains mostly adipocyte progenitor cells and ∼10% of small adipocytes. Using a 3-week 8% (2)H(2)O ingestion with a high-fat diet (HFD) or HFD plus pioglitazone (HFD-P), we demonstrate that the fractions of new aSV cells (f(aSV)) and immunopurified adipocytes (f(AD)) (the ratio of their (2)H-enrichment of DNA to the maximal (2)H-enrichment of DNA of bone marrow reference cells) recapitulate the known hyperplastic mechanism of weight gain with pioglitazone treatment. We conclude that f(aSV) and f(AD) are reliable indices of in vivo adipogenesis. The proposed method represents a valuable tool for studying the effect of interventions (drugs, diets, and exercise) on in vivo adipogenesis.
Enhancing adipose tissue plasticity: progenitor cell roles in metabolic health.
Lecoutre S, Rebiere C, Maqdasy S, Lambert M, Dussaud S, Abatan J Nat Rev Endocrinol. 2025; .
PMID: 39757324 DOI: 10.1038/s41574-024-01071-y.
Deletion of CD44 promotes adipogenesis by regulating PPARγ and cell cycle-related pathways.
Weng X, Jiang H, Walker D, Zhou H, Lin D, Wang J J Endocrinol. 2024; 262(1).
PMID: 38692289 PMC: 11227036. DOI: 10.1530/JOE-24-0079.
Measuring In Vivo Adipose Tissue Kinetics in Humans Using the Deuterium (2H)-Labeling Approach.
Kibodeaux D, Savoie J, Ravussin E, Fitch M, Hellerstein M, White U J Vis Exp. 2023; (197).
PMID: 37590512 PMC: 10521058. DOI: 10.3791/64883.
Richard A, Hang H, Allerton T, Zhao P, Mendoza T, Ghosh S Front Endocrinol (Lausanne). 2022; 13:812802.
PMID: 35464049 PMC: 9022209. DOI: 10.3389/fendo.2022.812802.
White U, Fitch M, Beyl R, Hellerstein M, Ravussin E Diabetologia. 2020; 64(1):159-167.
PMID: 33001232 PMC: 7718382. DOI: 10.1007/s00125-020-05281-7.